Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy.

Wu T, Dejanovic B, Gandham VD, Gogineni A, Edmonds R, Schauer S, Srinivasan K, Huntley MA, Wang Y, Wang TM, Hedehus M, Barck KH, Stark M, Ngu H, Foreman O, Meilandt WJ, Elstrott J, Chang MC, Hansen DV, Carano RAD, Sheng M, Hanson JE.

Cell Rep. 2019 Aug 20;28(8):2111-2123.e6. doi: 10.1016/j.celrep.2019.07.060.

2.

Disruption of IRE1α through its kinase domain attenuates multiple myeloma.

Harnoss JM, Le Thomas A, Shemorry A, Marsters SA, Lawrence DA, Lu M, Chen YA, Qing J, Totpal K, Kan D, Segal E, Merchant M, Reichelt M, Ackerly Wallweber H, Wang W, Clark K, Kaufman S, Beresini MH, Laing ST, Sandoval W, Lorenzo M, Wu J, Ly J, De Bruyn T, Heidersbach A, Haley B, Gogineni A, Weimer RM, Lee D, Braun MG, Rudolph J, VanWyngarden MJ, Sherbenou DW, Gomez-Bougie P, Amiot M, Acosta-Alvear D, Walter P, Ashkenazi A.

Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16420-16429. doi: 10.1073/pnas.1906999116. Epub 2019 Aug 1.

3.

A nature inspired modularity function for unsupervised learning involving spatially embedded networks.

Kishore R, Gogineni AK, Nussinov Z, Sahu KK.

Sci Rep. 2019 Feb 22;9(1):2631. doi: 10.1038/s41598-019-39180-8.

4.

Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease.

Le Pichon CE, Meilandt WJ, Dominguez S, Solanoy H, Lin H, Ngu H, Gogineni A, Sengupta Ghosh A, Jiang Z, Lee SH, Maloney J, Gandham VD, Pozniak CD, Wang B, Lee S, Siu M, Patel S, Modrusan Z, Liu X, Rudhard Y, Baca M, Gustafson A, Kaminker J, Carano RAD, Huang EJ, Foreman O, Weimer R, Scearce-Levie K, Lewcock JW.

Sci Transl Med. 2017 Aug 16;9(403). pii: eaag0394. doi: 10.1126/scitranslmed.aag0394.

5.

Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display.

Nair PM, Flores H, Gogineni A, Marsters S, Lawrence DA, Kelley RF, Ngu H, Sagolla M, Komuves L, Bourgon R, Settleman J, Ashkenazi A.

Proc Natl Acad Sci U S A. 2015 May 5;112(18):5679-84. doi: 10.1073/pnas.1418962112. Epub 2015 Apr 20.

6.

The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture.

Astarita JL, Cremasco V, Fu J, Darnell MC, Peck JR, Nieves-Bonilla JM, Song K, Kondo Y, Woodruff MC, Gogineni A, Onder L, Ludewig B, Weimer RM, Carroll MC, Mooney DJ, Xia L, Turley SJ.

Nat Immunol. 2015 Jan;16(1):75-84. doi: 10.1038/ni.3035. Epub 2014 Oct 27.

7.

Individual versus significant-other-enhanced brief motivational intervention for alcohol in emergency care.

Monti PM, Colby SM, Mastroleo NR, Barnett NP, Gwaltney CJ, Apodaca TR, Rohsenow DJ, Magill M, Gogineni A, Mello MJ, Biffl WL, Cioffi WG.

J Consult Clin Psychol. 2014 Dec;82(6):936-48. doi: 10.1037/a0037658. Epub 2014 Aug 11.

8.

Chronic GluN2B antagonism disrupts behavior in wild-type mice without protecting against synapse loss or memory impairment in Alzheimer's disease mouse models.

Hanson JE, Meilandt WJ, Gogineni A, Reynen P, Herrington J, Weimer RM, Scearce-Levie K, Zhou Q.

J Neurosci. 2014 Jun 11;34(24):8277-88. doi: 10.1523/JNEUROSCI.5106-13.2014.

9.

A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models.

Kallop DY, Meilandt WJ, Gogineni A, Easley-Neal C, Wu T, Jubb AM, Yaylaoglu M, Shamloo M, Tessier-Lavigne M, Scearce-Levie K, Weimer RM.

J Neurosci. 2014 May 7;34(19):6425-37. doi: 10.1523/JNEUROSCI.4963-13.2014.

10.

Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration.

Pozniak CD, Sengupta Ghosh A, Gogineni A, Hanson JE, Lee SH, Larson JL, Solanoy H, Bustos D, Li H, Ngu H, Jubb AM, Ayalon G, Wu J, Scearce-Levie K, Zhou Q, Weimer RM, Kirkpatrick DS, Lewcock JW.

J Exp Med. 2013 Nov 18;210(12):2553-67. doi: 10.1084/jem.20122832. Epub 2013 Oct 28.

11.

Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis.

Gogineni A, Caunt M, Crow A, Lee CV, Fuh G, van Bruggen N, Ye W, Weimer RM.

PLoS One. 2013 Jul 16;8(7):e68755. doi: 10.1371/journal.pone.0068755. Print 2013.

12.

Proapoptotic activation of death receptor 5 on tumor endothelial cells disrupts the vasculature and reduces tumor growth.

Wilson NS, Yang A, Yang B, Couto S, Stern H, Gogineni A, Pitti R, Marsters S, Weimer RM, Singh M, Ashkenazi A.

Cancer Cell. 2012 Jul 10;22(1):80-90. doi: 10.1016/j.ccr.2012.05.014.

13.

An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.

Adolfsson O, Pihlgren M, Toni N, Varisco Y, Buccarello AL, Antoniello K, Lohmann S, Piorkowska K, Gafner V, Atwal JK, Maloney J, Chen M, Gogineni A, Weimer RM, Mortensen DL, Friesenhahn M, Ho C, Paul R, Pfeifer A, Muhs A, Watts RJ.

J Neurosci. 2012 Jul 11;32(28):9677-89. doi: 10.1523/JNEUROSCI.4742-11.2012.

14.

Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms.

Goergen CJ, Azuma J, Barr KN, Magdefessel L, Kallop DY, Gogineni A, Grewall A, Weimer RM, Connolly AJ, Dalman RL, Taylor CA, Tsao PS, Greve JM.

Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):270-9. doi: 10.1161/ATVBAHA.110.216481. Epub 2010 Nov 11.

15.

Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis.

Li W, Wang BE, Moran P, Lipari T, Ganesan R, Corpuz R, Ludlam MJ, Gogineni A, Koeppen H, Bunting S, Gao WQ, Kirchhofer D.

Cancer Res. 2009 Nov 1;69(21):8395-402. doi: 10.1158/0008-5472.CAN-09-1995. Epub 2009 Oct 20.

16.

Readiness to change as a mediator of the effect of a brief motivational intervention on posttreatment alcohol-related consequences of injured emergency department hazardous drinkers.

Stein LA, Minugh PA, Longabaugh R, Wirtz P, Baird J, Nirenberg TD, Woolard RF, Carty K, Lee C, Mello M, Becker B, Gogineni A.

Psychol Addict Behav. 2009 Jun;23(2):185-95. doi: 10.1037/a0015648.

17.

Quantification of viable tumor microvascular characteristics by multispectral analysis.

Berry LR, Barck KH, Go MA, Ross J, Wu X, Williams SP, Gogineni A, Cole MJ, Van Bruggen N, Fuh G, Peale F, Ferrara N, Ross S, Schwall RH, Carano RA.

Magn Reson Med. 2008 Jul;60(1):64-72. doi: 10.1002/mrm.21470.

18.

Treatment completion in a brief motivational intervention in the emergency department: the effect of multiple interventions and therapists' behavior.

Baird J, Longabaugh R, Lee CS, Nirenberg TD, Woolard R, Mello MJ, Becker B, Carty K, Allison Minugh P, Stein L, Clifford PR, Gogineni A.

Alcohol Clin Exp Res. 2007 Oct;31(10 Suppl):71s-75s.

19.

pHUSH: a single vector system for conditional gene expression.

Gray DC, Hoeflich KP, Peng L, Gu Z, Gogineni A, Murray LJ, Eby M, Kljavin N, Seshagiri S, Cole MJ, Davis DP.

BMC Biotechnol. 2007 Sep 26;7:61.

20.

Cooperation of the proapoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin lymphoma xenografts.

Daniel D, Yang B, Lawrence DA, Totpal K, Balter I, Lee WP, Gogineni A, Cole MJ, Yee SF, Ross S, Ashkenazi A.

Blood. 2007 Dec 1;110(12):4037-46. Epub 2007 Aug 27.

PMID:
17724141
21.

Do patient intervention ratings predict alcohol-related consequences?

Lee CS, Longabaugh R, Baird J, Abrantes AM, Borrelli B, Stein LA, Woolard R, Nirenberg TD, Mello MJ, Becker B, Carty K, Clifford PR, Minugh PA, Gogineni A.

Addict Behav. 2007 Dec;32(12):3136-41. Epub 2007 Aug 3.

22.

Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models.

Chen Y, Clark S, Wong T, Chen Y, Chen Y, Dennis MS, Luis E, Zhong F, Bheddah S, Koeppen H, Gogineni A, Ross S, Polakis P, Mallet W.

Cancer Res. 2007 May 15;67(10):4924-32. Erratum in: Cancer Res. 2007 Jun 15;67(12):5998. Ross, Sarajane [added].

23.

Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma.

Polson AG, Yu SF, Elkins K, Zheng B, Clark S, Ingle GS, Slaga DS, Giere L, Du C, Tan C, Hongo JA, Gogineni A, Cole MJ, Vandlen R, Stephan JP, Young J, Chang W, Scales SJ, Ross S, Eaton D, Ebens A.

Blood. 2007 Jul 15;110(2):616-23. Epub 2007 Mar 20.

PMID:
17374736
24.

Female offspring of alcoholic individuals: recent findings on alcoholism and psychopathology risks: symposium presented at the Research Society on Alcoholism, 2004, Vancouver Aruna Gogineni, Chair.

Gogineni A, King S, Jackson K, Kramer J, Bucholz K, Chan G, Iacono W, Kuperman S, Larkins JM, Longabaugh R, McGue M, Polgreen L, Sher KJ, Stout R, Strong D, Woolard R.

Alcohol Clin Exp Res. 2006 Feb;30(2):377-87. No abstract available.

PMID:
16441287
25.

Oncogenic BRAF is required for tumor growth and maintenance in melanoma models.

Hoeflich KP, Gray DC, Eby MT, Tien JY, Wong L, Bower J, Gogineni A, Zha J, Cole MJ, Stern HM, Murray LJ, Davis DP, Seshagiri S.

Cancer Res. 2006 Jan 15;66(2):999-1006.

26.

Can the short index of problems (SIP) be improved? Validity and reliability of the three-month SIP in an emergency department sample.

Kenna GA, Longabaugh R, Gogineni A, Woolard RH, Nirenberg TD, Becker B, Minugh PA, Carty K, Clifford PR, Karolczuk K.

J Stud Alcohol. 2005 May;66(3):433-7.

PMID:
16047535
27.

Alcohol-related expectancies and assaults among injured drinkers in the emergency department setting.

Gogineni A, Longabaugh R, Clifford PR, Woolard R, Becker B, Minugh PA, Nirenberg T, Carty K.

Subst Abus. 2004 Jun;25(2):5-13.

PMID:
15982962
28.

Marijuana use and prior injury among injured problem drinkers.

Woolard R, Nirenberg TD, Becker B, Longabaugh R, Minugh PA, Gogineni A, Carty K, Clifford PR.

Acad Emerg Med. 2003 Jan;10(1):43-51.

29.

Alcohol, marijuana, and injury in the emergency department.

Woolard R, Nirenberg TD, Becker B, Longabaugh R, Minugh PA, Carty K, Gogineni A, Clifford PR.

Med Health R I. 2002 Oct;85(10):306-8. No abstract available.

PMID:
12412518
30.

Reduced aversion to oral capsaicin following neurotoxic destruction of superficial medullary neurons expressing NK-1 receptors.

Simons CT, Gogineni AG, Iodi Carstens M, Carstens E.

Brain Res. 2002 Jul 26;945(1):139-43.

PMID:
12113962
31.

Evaluating the effects of a brief motivational intervention for injured drinkers in the emergency department.

Longabaugh R, Woolard RE, Nirenberg TD, Minugh AP, Becker B, Clifford PR, Carty K, Licsw, Sparadeo F, Gogineni A.

J Stud Alcohol. 2001 Nov;62(6):806-16.

PMID:
11838918
32.

Social relationships and intravenous drug use among methadone maintenance patients.

Gogineni A, Stein MD, Friedmann PD.

Drug Alcohol Depend. 2001 Sep 1;64(1):47-53.

PMID:
11470340
33.

Interest in smoking cessation among injection drug users.

Clarke JG, Stein MD, McGarry KA, Gogineni A.

Am J Addict. 2001 Spring;10(2):159-66.

PMID:
11444157
34.

Validation of the screening strategy in the NIAAA "Physicians' Guide to Helping Patients with Alcohol Problems".

Friedmann PD, Saitz R, Gogineni A, Zhang JX, Stein MD.

J Stud Alcohol. 2001 Mar;62(2):234-8.

PMID:
11332444
35.

Factors associated with readiness to change drug use among needle-exchange users.

Bluthenthal RN, Gogineni A, Longshore D, Stein M.

Drug Alcohol Depend. 2001 May 1;62(3):225-30.

PMID:
11295327
36.

Adverse drinking consequences among alcohol abusing intravenous drug users.

Anderson BJ, Gogineni A, Charuvastra A, Longabaugh R, Stein MD.

Alcohol Clin Exp Res. 2001 Jan;25(1):41-5.

PMID:
11198713
37.

Alcohol expectancies as a mediator of the relationship between injury and readiness to change drinking behavior.

Ramsey SE, Gogineni A, Nirenberg TD, Sparadeo F, Longabaugh R, Woolard R, Becker BM, Clifford PR, Minugh PA.

Psychol Addict Behav. 2000 Jun;14(2):185-91.

PMID:
10860117
38.

Depression among needle exchange program and methadone maintenance clients.

Brienza RS, Stein MD, Chen M, Gogineni A, Sobota M, Maksad J, Hu P, Clarke J.

J Subst Abuse Treat. 2000 Jun;18(4):331-7.

PMID:
10812305
39.

Mediation and moderation in social work research.

Gogineni A, Alsup R, Gillespie DF.

Soc Work Res. 1995 Mar;19(1):57-63. Review. No abstract available.

PMID:
10141001
40.

Adult offspring of alcoholic women as family history informants.

Smith EM, Przybeck TR, Bradford SE, Gogineni A, Spitznagel EL.

Alcohol Clin Exp Res. 1994 Dec;18(6):1354-60.

PMID:
7695030
41.

Alcoholism treatment, severity of alcohol-related medical complications, and health services utilization.

Cook CA, Booth BM, Blow FC, Gogineni A, Bunn JY.

J Ment Health Adm. 1992 Spring;19(1):31-40.

PMID:
10128721

Supplemental Content

Loading ...
Support Center